Mepolizumab and pregnancy: A case of severe eosinophilic asthma in a patient who conceived during mepolizumab treatment

被引:0
|
作者
Aksu, Kurtulus [1 ]
Yagdiran, Melis [1 ]
Tuglu, Hatice Celik [1 ]
Telli, Onur [1 ]
Akkale, Ozgur [1 ]
Celik, Fatma Dindar [1 ]
机构
[1] Univ Hlth Sci, Ataturk Sanatoryum Training & Res Hosp, Dept Chest Dis, Div Immunol & Allergy, Ankara, Turkiye
关键词
Asthma; biological treatment; chronic eosinophilic pneumonia; mepolizumab; pregnancy;
D O I
10.14744/ejp.2024.1007
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
A 30-year-old female patient with steroid-dependent severe eosinophilic asthma and chronic eosinophilic pneumonia had been successfully treated with mepolizumab for 15 months. At the 16th month of mepolizumab treatment, she reported an unplanned pregnancy at four weeks gestation. Biological treatment was discontinued, and the patient was managed with a combination of inhaled corticosteroids (ICS), long-acting beta-agonists (LABA), and oral steroids. Despite experiencing frequent exacerbations during follow-up, appropriate treatments were administered. The patient delivered a healthy baby via normal spontaneous vaginal delivery at 39 weeks. In the management of pregnant women with asthma, the risk-benefit ratio of the medications used should be carefully evaluated, considering the potential risk of exacerbation or uncontrolled disease if the treatment is discontinued. In the presented case, after discontinuing mepolizumab treatment, the patient experienced three exacerbations despite regular use of systemic steroids. Keywords:
引用
收藏
页码:62 / 64
页数:3
相关论文
共 50 条
  • [1] Mepolizumab for the treatment of severe eosinophilic asthma
    Poulakos, Mara N.
    Cargill, Shawna M.
    Waineo, Melissa F.
    Wolford, Allen L., Jr.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (13) : 963 - 969
  • [2] Mepolizumab in the treatment of severe eosinophilic asthma
    Fainardi, Valentina
    Pisi, Giovanna
    Chetta, Alfredo
    IMMUNOTHERAPY, 2016, 8 (01) : 27 - 34
  • [3] Severe eosinophilic asthma and mepolizumab
    Walsh, Garry M.
    LANCET RESPIRATORY MEDICINE, 2016, 4 (07): : 528 - 529
  • [4] MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA
    Shahzad, Q.
    Zaheer, M.
    CHEST, 2020, 157 (06) : 275A - 275A
  • [5] Use of Mepolizumab in the Treatment of Severe Eosinophilic Asthma
    Strauss, R. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [6] Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
    Ortega, Hector G.
    Liu, Mark C.
    Pavord, Ian D.
    Brusselle, Guy G.
    FitzGerald, J. Mark
    Chetta, Alfredo
    Humbert, Marc
    Katz, Lynn E.
    Keene, Oliver N.
    Yancey, Steven W.
    Chanez, Pascal
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (13): : 1198 - 1207
  • [7] Mepolizumab for severe eosinophilic asthma
    Robinson, Douglas S.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2013, 7 (01) : 13 - 17
  • [8] Successful and safe treatment of severe steroid depended eosinophilic asthma with mepolizumab in a woman during pregnancy
    Vittorakis, Stylianos K.
    Giannakopoulou, Georgia
    Samitas, Konstantinos
    Zervas, Eleftherios
    RESPIRATORY MEDICINE CASE REPORTS, 2023, 41
  • [9] Mepolizumab (Nucala) for Severe Eosinophilic Asthma
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1486): : 11 - 12
  • [10] Case of paradoxical adverse response to mepolizumab with mepolizumab-induced alopecia in severe eosinophilic asthma
    Nixon, Rodanthe
    Despiney, Raquel
    Pfeffer, Paul
    BMJ CASE REPORTS, 2020, 13 (02)